CSRxP Applauds National Governors Association’s Commitment to Lowering Drug Prices

NGA’s “2019 Principles for Federal Action to Address Health Care Costs” Back Greater Competition, Boosted Transparency

 

For Immediate Release

Contact: Jon Conradi
860-235-3884
[email protected]

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to recommendations released by the National Governors Association (NGA) titled “2019 Principles for Federal Action to Address Health Care Costs.”

“We applaud America’s governors for working together in bipartisan collaboration to champion important guiding principles and critical market-based solutions to lower prescription drug prices in America,” said CSRxP executive director Lauren Aronson. “Many of the recommendations and principles outlined by the NGA strike at the core issue behind this crisis: The price-gouging, anti-competitive tactics of Big Pharma.”

“The momentum for action on prescription drug prices has never been greater and policymakers in Washington have made commendable strides on many solutions to increase competition and boost transparency,” Aronson added. “Lawmakers in Congress must keep up the momentum and continue to raise and advance bipartisan, market-based solutions to deliver relief for millions of American patients.”

Principles outlined by the NGA that are shared by CSRxP, include:

The NGA principles also include key, specific recommendations that have long been championed by CSRxP, including:

CSRxP encourages members of Congress to advance these, and other key market-based solutions, to lower prescription drug prices in America.

More on the legislative solutions supported by CSRxP can be found HERE.

The full NGA release can be found HERE.

 

 

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.